elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37785871-8B05F671-2E07-4E10-80F6-EEF6782FC197
Q37785871-8B05F671-2E07-4E10-80F6-EEF6782FC197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37785871-8B05F671-2E07-4E10-80F6-EEF6782FC197
Progress in the development of therapeutic antibodies targeting prion proteins and beta-amyloid peptides.
P2860
Q37785871-8B05F671-2E07-4E10-80F6-EEF6782FC197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37785871-8B05F671-2E07-4E10-80F6-EEF6782FC197
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4f636429c753ba5aa414c4c830d10da4d8cd5a6
P2860
Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.